Send your queries and feedback on this paper by contacting the author.
The ACIP�s recommendation of influenza vaccination during pregnancy is not supported by citations in its own policy paper or in current medical literature. Considering the potential risks of maternal and fetal mercury exposure, the administration of thimerosal during pregnancy is both unjustified and unwise. Pregnancy should continue to be a time when doctors are highly protective of their patients with regard to any fetal exposure. Without adequate safety testing, a risk-benefit analysis of influenza vaccination during pregnancy is not possible, and therefore the ACIP�s present recommendation should be withdrawn.
Reprinted with Permission from www.jpands.org and www.aapsonline.org
Journal of American Physicians and Surgeons Volume 11 Number 2 Summer 2006
:: IDS Emergency Management :: IDS Water ::IDS Publishing / Media::IDS Packaging::IDS Environment::IDS Plastics::IDS Power/Energy::
Industry IDS, Inc. – Online Tradeshow, Exhibition, & Buyers Guide Solutions
